4.7 Article

Eating and Hypothalamus Changes in Behavioral-Variant Frontotemporal Dementia

期刊

ANNALS OF NEUROLOGY
卷 69, 期 2, 页码 312-319

出版社

WILEY-BLACKWELL
DOI: 10.1002/ana.22244

关键词

-

资金

  1. National Health and Medical Research Council (NHMRC) [510106, 510184]
  2. NHMRC of Australia
  3. University of New South Wales
  4. Neuroscience Research Australia
  5. Australian Research Council Federation [FF0776229]
  6. Swedish Research Council
  7. province of Scania

向作者/读者索取更多资源

Objective: Behavioral-variant frontotemporal dementia (bvFTD) is a progressive neurodegenerative brain disorder, clinically characterized by changes in cognition, personality, and behavior. Marked disturbances in eating behavior, such as overeating and preference for sweet foods, are also commonly reported. The hypothalamus plays a critical role in feeding regulation, yet the relation between pathology in this region and eating behavior in FTD is unknown. This study aimed to address this issue using 2 complementary approaches. Methods: First, 18 early stage bvFTD patients and 16 healthy controls underwent high-resolution structural magnetic resonance imaging and assessment of eating behavior. Hypothalamic volumes were traced manually on coronal images. Second, postmortem analyses of 12 bvFTD cases and 6 matched controls were performed. Fixed hypothalamic tissue sections were stained for a cell marker and for peptides regulating feeding behaviors using immunohistochemistry. Stereo logical estimates of the hypothalamic volume and the number of neurons and glia were performed. Results: Significant atrophy of the hypothalamus in bvFTD was present in both analyses. Patients with high feeding disturbance exhibited significant atrophy of the posterior hypothalamus. Neuronal loss, which was observed only in bvFTD cases with Tar DNA protein-43 deposition, was also predominant posteriorly. In contrast, orexin (hypocretin), neuropeptide Y, cocaine- and amphetamine-regulating transcript, and vasopressin-containing neurons that regulate appetite were spared in posterior nuclei known to participate in feeding regulation. Interpretation: Degeneration and consequent dysregulation within the hypothalamus relates to significant feeding disturbance in bvFTD. These findings provide a basis for the development of therapeutic models. ANN NEUROL 2011;69:312-319

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Geriatrics & Gerontology

The Acceptability and Usefulness of Positive Behaviour Support Education for Family Carers of People With Frontotemporal Dementia: A Pilot Study

Alinka C. Fisher, Sau C. Cheung, Claire M. C. O'Connor, Olivier Piguet

Summary: This pilot study investigated the acceptability and usefulness of a Positive Behaviour Support (PBS) education program for family carers of individuals with behavioural-variant frontotemporal dementia (bvFTD). The results indicate that the program was helpful in improving the carers' capability in providing behaviour support, with positive changes observed in their approach.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2023)

Review Psychology, Clinical

Current Potential for Clinical Optimization of Social Cognition Assessment for Frontotemporal Dementia and Primary Psychiatric Disorders

Jan Van den Stock, Maxime Bertoux, Janine Diehl-Schmid, Olivier Piguet, Katherine P. Rankin, Florence Pasquier, Simon Ducharme, Yolande Pijnenburg, Fiona Kumfor

Summary: Dodich et al. reviewed the clinical use of social cognition assessment in behavioral variant frontotemporal dementia and proposed an initiative to address the limitations in their study.

NEUROPSYCHOLOGY REVIEW (2023)

Review Clinical Neurology

The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis

Bonnie Yin Ka Lam, Yuan Cai, Rufus Akinyemi, Geert Jan Biessels, Hilde van den Brink, Christopher Chen, Chin Wai Cheung, King Ngai Chow, Henry Kwun Hang Chung, Marco Duering, Siu Ting Fu, Deborah Gustafson, Saima Hilal, Vincent Ming Ho Hui, Rajesh Kalaria, Sang Yun Kim, Maggie Li Man Lam, Frank Erik de Leeuw, Ami Sin Man Li, Hugh Stephen Markus, Anna Marseglia, Huijing Zheng, John O'Brien, Leonardo Pantoni, Perminder Singh Sachdev, Eric E. Smith, Joanna Wardlaw, Vincent Chung Tong Mok

Summary: This study systematically reviewed the prevalence of cerebral small vessel disease (cSVD) in low- and middle-income countries (LMICs). The results demonstrated a high prevalence of cSVD in LMICs. There is a need for more data from different regions to support the findings, as there is currently bias in the available studies.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Psychology

Development of the Basel Version of the Awareness of Social Inference Test - Theory of Mind (BASIT-ToM) in healthy adults

Marianne Jarsch, Olivier Piguet, Manfred Berres, Constantin Sluka, Anna Semenkova, Reto W. Kressig, Andreas U. Monsch, Skye McDonald, Marc Sollberger

Summary: This study aimed to develop the first German-language adaptation of TASIT-SIM, an ecologically valid test for assessing Theory of Mind (ToM) abilities in healthy adults. Thirteen scenes were selected and filmed at different intensities to determine the best materials for the test. Through Rasch analysis, intensity versions were chosen that showed optimal performance in participants with medium ToM abilities. In conclusion, the Basel Version of the Awareness of Social Inference Test - Theory of Mind (BASIT-ToM) was developed, incorporating the strengths of TASIT-SIM and addressing its limitations. Further validation of BASIT-ToM is needed in both healthy and clinical populations.

JOURNAL OF NEUROPSYCHOLOGY (2023)

Correction Clinical Neurology

Adaptive structural changes in the motor cortex and white matter in Parkinson's disease (vol 144, pg 861, 2022)

YuHong Fu, Liche Zhou, Hongyun Li, Jen-Hsiang T. Hsiao, Binyin Li, Onur Tanglay, Andrew D. Auwyang, Elinor Wang, Jieyao Feng, Woojin S. Kim, Jun Liu, Glenda M. Halliday

ACTA NEUROPATHOLOGICA (2023)

Letter Clinical Neurology

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis

Srestha Mazumder, Heather McCann, Susan D'Silva, Sarah Furlong, Claire E. Shepherd, Jillian J. Kril, Glenda M. Halliday, Dominic B. Rowe, Matthew C. Kiernan, Rachel H. Tan

Article Clinical Neurology

Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation

Yannie Soo, Annaelle Zietz, Brian Yiu, Vincent C. T. Mok, Alexandros A. Polymeris, David Seiffge, Gareth Ambler, Duncan Wilson, Thomas Wai Hong Leung, Suk Fung Tsang, Winnie Chu, Jill Abrigo, Cyrus Cheng, Keon-Joo Lee, Jae-Sung Lim, Masayuki Shiozawa, Masatoshi Koga, Hugues Chabriat, Michael Hennerici, Yuen Kwun Wong, Henry Mak, Roger Collet, Shigeru Inamura, Kazuhisa Yoshifuji, Ethem Murat Arsava, Solveig Horstmann, Jan Purrucker, Bonnie Y. K. Lam, Adrian Wong, Young Dae Kim, Tae-Jin Song, Robin Lemmens, Sebastian Eppinger, Thomas Gattringer, Ender Uysal, Derya Selcuk Demirelli, Natan M. Bornstein, Einor Ben Assayag, Hen Hallevi, Jeremy Molad, Masashi Nishihara, Jun Tanaka, Shelagh B. Coutts, L. Jaap Kappelle, Rustam Al-Shahi Salman, Rolf Jager, Gregory Y. H. Lip, Martina B. Goeldlin, Leonidas D. Panos, Jean-Louis Mas, Laurence Legrand, Chris Karayiannis, Thanh Phan, Maximilian Bellut, Francesca Chappell, Stephen Makin, Derek Hayden, David Williams, Dianne H. K. van Dam-Nolen, Paul J. Nederkoorn, Carmen Barbato, Simone Browning, Kim Wiegertjes, Anil Man Tuladhar, Anne-Marie Mendyk, Sebastian Kohler, Robert van Oostenburgge, Ying Zhou, Chao Xu, Saima Hilal, Bibek Gyanwali, Christopher Chen, Min Lou, Julie Staals, Regis Bordet, Nagaendran Kandiah, Frank-Erik de Leeuw, Robert Simister, Jeroen Hendrikse, Joanna Wardlaw, Peter Kelly, Felix Fluri, Velandai Srikanth, David Calvet, Simon Jung, Vincent I. H. Kwa, Eric E. Smith, Hideo Hara, Yusuke Yakushiji, Dilek Necioglu Orken, Franz Fazekas, Vincent Thijs, Ji-Hoe Heo, Roland Veltkamp, Hakan Ay, Toshio Imaizumi, Kui Kai Lau, Eric Jouvent, Kazunori Toyoda, Sohei Yoshimura, Hee-Joon Bae, Joan Marti-Fabregas, Luis Prats-Sanchez, Philippe Lyrer, Jonathan Best, David Werring, Stefan T. Engelter, Nils Peters

Summary: This study aimed to evaluate the risks of intracranial hemorrhage and ischemic stroke associated with microbleeds in atrial fibrillation patients. The results showed that the presence of microbleeds increased the relative risk of hemorrhage and stroke. In patients taking a combination of anticoagulant and antiplatelet therapy, the risk of intracranial hemorrhage was higher than that of ischemic stroke.

ANNALS OF NEUROLOGY (2023)

Article Behavioral Sciences

Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease

Jessica L. Hazelton, Sol Fittipaldi, Matias Fraile-Vazquez, Marion Sourty, Agustina Legaz, Anna L. Hudson, Indira Garcia Cordero, Paula C. Salamone, Adrian Yoris, Agustin Ibanez, Olivier Piguet, Fiona Kumfor

Summary: This study investigates the disease-specific mechanisms underlying emotion recognition difficulties in bvFTD, AD, and PD patients. The findings suggest that interoceptive accuracy and cognitive abilities may contribute to emotion recognition impairments. In particular, bvFTD patients show worse interoceptive accuracy, while AD and PD patients show worse cognition.

CORTEX (2023)

Article Clinical Neurology

Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS

Yue Yang, Dominic Rowe, Heather McCann, Claire E. Shepherd, Jillian J. Kril, Matthew C. Kiernan, Glenda M. Halliday, Rachel H. Tan

Summary: This study compared the pathology of ALS patients who received CuATSM and riluzole with those who only received riluzole, and found no significant difference in neuron density or TDP-43 burden. However, CuATSM treatment led to the presence of p62-immunoreactive astrocytes in the motor cortex and reduced Iba1 density in the spinal cord. There was no significant difference in astrocytic activity and SOD1 immunoreactivity with CuATSM treatment.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Multidisciplinary Sciences

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting

Priscilla Youssef, Laura Hughes, Woojin S. Kim, Glenda M. Halliday, Simon J. G. Lewis, Antony Cooper, Nicolas Dzamko

Summary: Objective biomarkers for Parkinson's Disease (PD) could aid early and specific diagnosis, effective monitoring of disease progression, and improved design and interpretation of clinical trials. In this study, the potential of the SIMOA neurology 4-plex-A marker panel, along with plasma alpha-synuclein, as biomarkers for PD diagnosis and prognosis was assessed. The levels of NFL and GFAP in plasma positively correlated with alpha-synuclein levels, while as disease state biomarkers, NFL and GFAP showed correlation with motor severity and stage.

SCIENTIFIC REPORTS (2023)

Article Multidisciplinary Sciences

Elevated GRO-alpha and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia

Hiu Chuen Lok, Jared S. Katzeff, John R. Hodges, Olivier Piguet, YuHong Fu, Glenda M. Halliday, Woojin Scott Kim

Summary: Neuroinflammation is a key feature of frontotemporal dementia (FTD), characterized by the degeneration of the frontal and temporal lobes. This study examined 48 cytokines in FTD serum and brain tissues to identify common dysregulation pathways. The results suggest the potential importance of the NLRP3 inflammasome in FTD.

SCIENTIFIC REPORTS (2023)

Article Clinical Neurology

Survival in sporadic ALS is associated with lower p62 burden in the spinal cord

Monica Pinkerton, Guinevere Lourenco, Maria Torres Pacheco, Glenda M. Halliday, Matthew C. Kiernan, Rachel H. Tan

Summary: This study aimed to assess the pathology of p62 in sporadic ALS patients and determine its association with disease pathology. The results identified more cytoplasmic p62 aggregates in patients with a shorter disease duration. The findings support further research on p62 as a potential prognostic biomarker in ALS.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

Letter Clinical Neurology

Effects of STN/SNr deep brain stimulation in a case of progressive supranuclear palsy with a Parkinson disease phenotype

Claire E. Shepherd, Simon J. G. Lewis, Stephen Tisch, Heather McCann, Ben Jonker, Glenda M. Halliday

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2023)

Article Clinical Neurology

Past antihypertensive medication use is associated with lower levels of small vessel disease and lower A & beta; plaque stage in the brains of older individuals

Andrew J. Affleck, Perminder S. Sachdev, Glenda M. Halliday

Summary: This study examines the impact of antihypertensive medication use on the severity of neuropathological cerebrovascular disease in older individuals. The results suggest that antihypertensive medication use is associated with less severe white matter small vessel disease. However, there is no significant relationship between medication use and infarction, lacunes, or cerebral amyloid angiopathy. Antihypertensive medication use reduces white matter rarefaction and Aβ propagation through the brain, specifically in individuals with moderate to severe white matter small vessel disease.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Cell Biology

A blood-based marker of mitochondrial DNA damage in Parkinson's disease

Rui Qi, Esther Sammler, Claudia P. Gonzalez-Hunt, Ivana Barraza, Nicholas Pena, Jeremy P. Rouanet, Yahaira Naaldijk, Steven Goodson, Marie Fuzzati, Fabio Blandini, Kirk I. Erickson, Andrea M. Weinstein, Michael W. Lutz, John B. Kwok, Glenda M. Halliday, Nicolas Dzamko, Shalini Padmanabhan, Roy N. Alcalay, Cheryl Waters, Penelope Hogarth, Tanya Simuni, Danielle Smith, Connie Marras, Francesca Tonelli, Dario R. Alessi, Andrew B. West, Sruti Shiva, Sabine Hilfiker, Laurie H. Sanders

Summary: Parkinson's disease (PD) is a common neurodegenerative movement disorder in which mitochondrial dysfunction plays a key role. This study developed a PCR-based assay called Mito DNADX to accurately quantify mitochondrial DNA (mtDNA) damage. The assay revealed increased mtDNA damage in peripheral blood cells from PD patients and those with a PD-associated mutation. In addition, it was found that LRRK2 kinase inhibitors could mitigate mtDNA damage in animal models and patient-derived cells. This study suggests that quantifying mtDNA damage may serve as a potential biomarker for PD and for assessing the effectiveness of LRRK2 kinase inhibitors.

SCIENCE TRANSLATIONAL MEDICINE (2023)

暂无数据